MedTrace Logo

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

NCT01091519 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 781

Last updated 2013-03-07

Study results available
· View outcomes & findings →

Summary

Collect information on treatment with Toviaz (fesoterodine) under ordinary prescribing conditions, and to investigate whether additional educational information affects satisfaction with treatment as perceived by the patient.

Conditions

  • Urinary Bladder, Overactive

Interventions

OTHER

Toviaz(fesoterodine) plus educational materials

Educational materials including the Self-Assessment Goal Achievement (SAGA) tool to support dialogue.

OTHER

Toviaz(fesoterodine) without educational materials

No educational materials

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091519 on ClinicalTrials.gov